Michael Pine Email and Phone Number
Michael Pine work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Michael Pine personal email
- Valid
Michael Pine phone numbers
Over 20 years of relevant experience in small, medium and large pharmaceutical companies as a business leader, building a deep and broad C-Suite pharmaceutical executive skill set that includes: Strategy, Leadership, BD&L Negotiations, BD&L Search & Evaluation, M&A, Investment Banking, Product Marketing, Alliance Management, Market Access, Operations, and Managed Markets, built on a B.S. from Cornell and an MBA from Columbia Business School. I have been fortunate to contribute to high-level strategic decisions at the Senior Management/Board levels while at Chase, Wyeth, Pfizer, Organon, Kos Pharmaceuticals, Novartis, Aralez, Lupin, Medexus and now Eyepoint. I have utilized my skills and experience to not only build a strong deal sheet, but importantly to also utilize strategy and insight for the discretion to walk when appropriate. I have managed strong teams while conducting strategic and transformational deals to create significant value. My breadth of experience has provided optimal evaluation and negotiation strategies, incorporating commercial and managed market perspectives into key decisions. I have developed a deep understanding of the pharmaceutical industry, the challenges that we face, both today and tomorrow, and strategies for the future of US healthcare. I’ve had the honor of speaking at industry conferences and panels, and have enjoyed volunteering my time to help others meet their goals. My strengths include my ability to critically analyze a situation, rapidly develop and evaluate solutions (both financially and strategically), build consensus, and clearly present recommendations to negotiate superior terms. I feel confident in my ability to tackle any challenge and feel strongly that there are "solutions" to all problems. I have developed a large professional network as I have been lucky to work with outstanding people through my career. My goal is to utilize my experience and skills at the most senior level to make impactful business decisions and grow my company.Specialties: Negotiations, strategic thinking, assessing/evaluating opportunities/challenges, financial analysis, creative terms, licensing, problem solving, networking
-
Chief Business OfficerEyepoint Pharmaceuticals Jan 2022 - Present- Corporate Officer with broad responsibility for public biopharma with promising Phase II ophthalmology asset to provide long-term solutions in areas of ophthalmic unmet need- Leading Business & Corporate Development efforts for inlicensing, outlicensing, and other partnering initiatives- Responsible for corporate strategy and M&A as company evolves from commercially-focused company into development-stage biopharma organization focused on identifying and delivering new treatments using our leading, sustained-release intravitreal delivery to posterior segment technology
-
Chief Corporate Development & Strategy OfficerEyepoint Pharmaceuticals Jan 2022 - Oct 2023- Corporate Officer with broad responsibility for public biopharma with promising Phase II ophthalmology asset to provide long-term solutions in areas of ophthalmic unmet need- Leading Business & Corporate Development efforts for inlicensing, outlicensing, and other partnering initiatives- Responsible for corporate strategy and M&A as company evolves from commercially-focused company into development-stage biopharma organization focused on identifying and delivering new treatments using our leading, sustained-release intravitreal delivery to posterior segment technology
-
Senior Vice President Business Development & StrategyMedexus Pharmaceuticals, Inc. Sep 2020 - Jan 2022Chicago, Il, Us- Responsible for inorganic growth strategy and execution for growing public company with >C$100M in sales and positive adjusted EBITDA, focused on late stage and on-market assets for the North American market- Member of small management team aggressively seeking to grow via complementary partnerships and acquisitions, leveraging a strong commercial infrastructure in the US (Stem Cell Transplant, Rheumatology, Hematology, Oncology, Rare Disease) and Canada (GPs, Allergy, Specialty Oncology, Opportunistic)- Five transactions completed in first 9 months contributing to a 2.5x increase in market capitilzation and graduation to TSX Big Board -
Independent Bd ConsultantIndependent Consultant Jun 2020 - Aug 2020- BD Consultant for 4 companies; co-promotion, acquisition, platform technology and ex-US out-licensing- Successfully evaluated, negotiated and closed a co-promotion deal for Eyepoint (NASDAQ: EYPT) and reached negotiation stage with another company (confidential) over a 3 month period
-
Senior Vice President Business Development - Global Specialty (Branded) ProductsLupin Pharmaceuticals Feb 2019 - May 2020Somerset, Nj, Us- Focused BD&L efforts to grow/evolve a ~$2.3B net sales, $5B+ mkt cap company into a leading branded, specialty pharmaceutical company- Responsible for identifying, evaluating, negotiating and executing licenses, acquisitions, spin-outs, joint ventures, co-promotions, and other creative structures- Negotiated and closed a deal for a complementary women's health asset -
Vice President, Corporate Development & LicensingAralez Pharmaceuticals Inc. Aug 2015 - Jan 2019Mississauga, Ontario, Ca- Identified, evaluated, negotiated and completed six transactions for up to $340M- Responsible for developing and executing inorganic growth strategy for entrepreneurial, commercial stage public pharmaceutical company, backed by Deerfield Partners- Led cross-functional team, evaluating over 150 opportunities, 30 diligences and 13 negotiations- Hired and directed Sr. Director of CD&L to manage alliances and expand therapeutic platform -
Director, Head Of Operations & Analytics, Us Managed MarketsNovartis Dec 2013 - Jul 2015Basel, Baselstadt, Ch- Provided strategic insight and direction for US Managed Markets including payer marketing, pricing & contracting, supply & distribution, and account management - Led team of 5 direct and 7 indirect reports; department responsbilities include coordination of budget, IT, training, analytics, communications, HR. - Member of management team, leading and overseeing up to 1,000 colleagues.- Created presentations and speeches for VP USMM; represented USMM cross-functionally throughout organization -
Director, Market Access Strategies, Us Managed MarketsNovartis Aug 2011 - Dec 2013Basel, Baselstadt, Ch- Developed and implemented market access strategies for Gilenya, Fanapt, TOBI, Serelaxin- Created and implemented innovative pricing and access strategy for TOBI Podhaler launch- Led 2, 25+ person cross-functional teams including Pharmacy, Patient Services, Adherence- Directed analysis and HEOR to develop value proposition and materials to optimize access- Developed pricing and contracting strategies to maximize profitability - high level of success in 2013 resulted in excellent access and exceeded budgetary goals.
-
Marketing & Alliance ManagementNovartis Feb 2010 - Aug 2011Basel, Baselstadt, Ch- Head of Alliance Management on 2 marketed pharmaceutical products (womens health) and Brand Management for a third pharmaceutical launch brand (psychiatry) within the Neuro/Psych Operating Unit.• Fanapt (iloperidone), launch brand: Peer to Peer/KOL programs, war gaming, brand strategy• Vivelle Dot (estradiol patch): Alliance manager, negotiator for Novogyne Joint Venture• Comtan/Stalevo (entacapone): Professional and consumer marketing, contest development• Member of Novogyne Management Committee; Budget and P&L approval responsibilities
-
Director, Us Business Development & LicensingNovartis Apr 2007 - Jul 2011Basel, Baselstadt, Ch• Lead for sourcing, evaluating and negotiating licensing and co-promotion projects• Represented US interests in internal and external negotiations for global partnerships• Received Business Excellence Award for leading and closing Elidel Co-Promotion• Novartis Leadership Program, Executive Diversity & Inclusion Committee, Leading Innovation• Responsible for due diligence, creative deal structures, problem solving, M&A assessments
-
Director, Business Development & LicensingKos Pharmaceuticals Jan 2006 - Mar 2007UsShared responsibility for all licensing, partnering, alliance management, acquisition and divestiture activity for Kos Pharmaceuticals, ranked #6 on Fortune Magazine's fastest growing companies. -
Director Of Business DevelopmentOrganon Pharmaceuticals Aug 2004 - Jan 2006Us• Responsible for all corporate sourcing, evaluating, and negotiating for strategic partnerships • Manager of industry-leading Women’s Health Care global business development efforts • Led matrixed teams in assessing and prioritizing opportunities in numerous therapeutic areas. -
Senior Manager - New Product Development Licensing & AcquisitionsPfizer Nov 2001 - Aug 2004New York, New York, UsAnalysis of in and out-licensing opportunities, creation of deal terms, aid in negotiation of acquisitions of drug candidates from other pharma/biotech companies, analysis of acquisition opportunities, internal consulting and problem solving on complex operational issues, overall strategy development for licensing portfolio -
Assistant Brand ManagerWyeth May 2000 - Aug 2000New York, New York, Us• Used problem solving and research skills to create marketing plan, forecast sales and plan media budget for a new “Advil Cold & Sinus” product; participated in DTC planning for “Advil Flu”• Managed cross-functional team of sales, media, product development and research
-
Sr. Financial AnalystJp Morgan Chase Jul 1997 - Aug 1999New York, Ny, Us• Performed analysis, valuations and financial modeling on various companies for possible mergers and acquisitions; communicated results to senior management teams• Produced pitch books, prospectuses, and sales memoranda raising over $2 billion
Michael Pine Skills
Michael Pine Education Details
-
Columbia Business SchoolFinance -
Cornell UniversityMarketing
Frequently Asked Questions about Michael Pine
What company does Michael Pine work for?
Michael Pine works for Eyepoint Pharmaceuticals
What is Michael Pine's role at the current company?
Michael Pine's current role is Chief Business Officer at EyePoint Pharmaceuticals.
What is Michael Pine's email address?
Michael Pine's email address is mp****@****ail.com
What is Michael Pine's direct phone number?
Michael Pine's direct phone number is +121249*****
What schools did Michael Pine attend?
Michael Pine attended Columbia Business School, Cornell University.
What skills is Michael Pine known for?
Michael Pine has skills like Pharmaceutical Industry, Strategy, Cross Functional Team Leadership, Biotechnology, Business Development, Product Launch, Mergers And Acquisitions, Market Access, Licensing, Management, Oncology, Mergers.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial